Related Experiment Video
Updated: May 17, 2026
09:50
Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications
Published on: December 22, 2023
Advances in clinical study of curcumin
Chunfen Yang1, Xun Su, Anchang Liu
1Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan 250012, China.
Current Pharmaceutical Design
|November 3, 2012
Summary
Curcumin shows promise for treating various diseases, including cancers and inflammatory conditions. Clinical trials confirm its safety and effectiveness, supporting its therapeutic potential.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Clinical Medicine
Background:
- Curcumin, a compound from turmeric, exhibits significant anti-cancer and anti-inflammatory properties.
- It is being investigated for conditions such as breast cancer, rheumatoid arthritis, Alzheimer's disease, and colorectal cancer.
Purpose of the Study:
- To review and summarize existing clinical studies on curcumin's efficacy and safety.
- To provide a reference for future research into curcumin's therapeutic applications.
Main Methods:
- Literature review of clinical trials involving curcumin.
- Analysis of reported outcomes and safety data from human studies.
Main Results:
- Multiple clinical trials indicate that curcumin is generally safe for patients.
- Evidence suggests curcumin is effective in managing various health conditions.
Conclusions:
- Curcumin is a safe and effective agent with broad therapeutic potential.
- Further clinical studies are warranted to fully elucidate its benefits and applications.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...